SenzaGen’s Newsletter Q1 2021
Click image to read the newsletter.
Entries by
Winner of the MDCPSS Best Overall Abstract Award at 2021 SOT!🏅
At this year’s Society of Toxicology annual meeting SenzaGen’s in vitro Medical Device test method was awarded the Best Overall Abstract Award in the Medical Device and Combination Product Specialty Section. Authors Joshua J. Schmidt, Ph.D. Ron Brown Rose-Marie Jenvert, PhD Abstract 3020: Poster Board – P158: Applicability Domain of the GARDskin Medical Device Test […]
BioStock Studio: SenzaGen is aiming to increase market activity in 2021
In this interview CEO Axel Sjöblad comments the 2020 year-end report, ongoing projects, and the way forward.
Join SenzaGen’s hosted session at 2021 SOT
Are you attending the 2021 SOT Annual Meeting and ToxExpo? Come join our workshop presentation, hosted session and poster presentations to hear the latest news about GARD™ and how the assays are used for skin sensitization testing! Click image for more details about the program!
SenzaGen’s CEO comments on the 2020 Year-end report
SenzaGen’s sales during the full year 2020 tripled compared to 2019. Listen to CEO Axel Sjöblad commenting the 2020 performance in today’s conference call. Listen to CEO comment
Watch our latest webinar recording!
Thanks to all who attended our webinar ‘Why choose GARD for skin sensitization testing?’ last week. If you were not able to attend live, and wish to watch it, you can now access the webinar’s recording! Watch recording here!
Season’s greetings from all of us at SenzaGen
We wish you a truly happy holiday season, and we look forward to seeing you again in the new year. 2020 Highlights SenzaGen received GLP approval We can now offer GLP-compliant test services using the GARD™platform. Read more GARD™skin Dose-Response This newly released assay provides quantitative potency information related to skin sensitization. Learn more […]
CEO presentation at Redeye Life Science Day
Our CEO Axel Sjöblad gave an update on our commercial progress at Redeye Life Science Day last week. Watch the replay here:
RIFM Principle Scientist Gretchen Ritacco speaks about SenzaGen and RIFM collaboration
Here is an interview with Principal Scientist Gretchen Ritacco, MS, explaining why RIFM has focused some of its research on the potential for light to activate fragrance materials resulting in reactions in the body’s largest organ, the skin. Since June 2020, SenzaGen and the Research Institute for Fragrance Materials (RIFM) are collaborating to investigate in […]
Webinar: Safer Medical Devices
Safer Medical Devices – in vitro skin sensitization testing with human relevance and high accuracy By Rose-Marie Jenvert, PhD, and Joshua Schmidt, PhD, SenzaGen Watch by clicking the image below.
